SkinBioTherapeutics Plc

SBTX.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income£0-£1-£2-£1
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£0
Change in WC-£1£0-£0£0
Other Non-Cash-£0-£0£0-£0
Operating Cash Flow-£0-£1-£1-£1
Investing Activities
PP&E Inv.-£0-£0-£0-£0
Net Acquisitions-£0-£1-£2£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0£0£0-£0
Investing Cash Flow-£0-£2-£2-£0
Financing Activities
Debt Repay.£0£1£1-£0
Stock Issued£4£2£0£3
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£0-£0-£0£0
Financing Cash Flow£4£3£2£3
Forex Effect£0£0£0£0
Net Chg. in Cash£4£0-£2£2
Supplemental Information
Beg. Cash£1£1£3£1
End Cash£5£1£1£3
Free Cash Flow-£0-£1-£1-£1